Cargando…
A new scoring system for predicting survival in patients with non-small cell lung cancer
This analysis was performed to create a scoring system to estimate the survival of patients with non-small cell lung cancer (NSCLC). Data from 1274 NSCLC patients were analyzed to create and validate a scoring system. Univariate (UV) and multivariate (MV) Cox models were used to evaluate the prognos...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567018/ https://www.ncbi.nlm.nih.gov/pubmed/26108458 http://dx.doi.org/10.1002/cam4.479 |
_version_ | 1782389760842530816 |
---|---|
author | Schild, Steven E Tan, Angelina D Wampfler, Jason A Ross, Helen J Yang, Ping Sloan, Jeff A |
author_facet | Schild, Steven E Tan, Angelina D Wampfler, Jason A Ross, Helen J Yang, Ping Sloan, Jeff A |
author_sort | Schild, Steven E |
collection | PubMed |
description | This analysis was performed to create a scoring system to estimate the survival of patients with non-small cell lung cancer (NSCLC). Data from 1274 NSCLC patients were analyzed to create and validate a scoring system. Univariate (UV) and multivariate (MV) Cox models were used to evaluate the prognostic importance of each baseline factor. Prognostic factors that were significant on both UV and MV analyses were used to develop the score. These included quality of life, age, performance status, primary tumor diameter, nodal status, distant metastases, and smoking cessation. The score for each factor was determined by dividing the 5-year survival rate (%) by 10 and summing these scores to form a total score. MV models and the score were validated using bootstrapping with 1000 iterations from the original samples. The score for each prognostic factor ranged from 1 to 7 points with higher scores reflective of better survival. Total scores (sum of the scores from each independent prognostic factor) of 32–37 correlated with a 5-year survival of 8.3% (95% CI = 0–17.1%), 38–43 correlated with a 5-year survival of 20% (95% CI = 13–27%), 44–47 correlated with a 5-year survival of 48.3% (95% CI = 41.5–55.2%), 48–49 correlated to a 5-year survival of 72.1% (95% CI = 65.6–78.6%), and 50–52 correlated to a 5-year survival of 84.7% (95% CI = 79.6–89.8%). The bootstrap method confirmed the reliability of the score. Prognostic factors significantly associated with survival on both UV and MV analyses were used to construct a valid scoring system that can be used to predict survival of NSCLC patients. Optimally, this score could be used when counseling patients, and designing future trials. |
format | Online Article Text |
id | pubmed-4567018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45670182015-09-17 A new scoring system for predicting survival in patients with non-small cell lung cancer Schild, Steven E Tan, Angelina D Wampfler, Jason A Ross, Helen J Yang, Ping Sloan, Jeff A Cancer Med Clinical Cancer Research This analysis was performed to create a scoring system to estimate the survival of patients with non-small cell lung cancer (NSCLC). Data from 1274 NSCLC patients were analyzed to create and validate a scoring system. Univariate (UV) and multivariate (MV) Cox models were used to evaluate the prognostic importance of each baseline factor. Prognostic factors that were significant on both UV and MV analyses were used to develop the score. These included quality of life, age, performance status, primary tumor diameter, nodal status, distant metastases, and smoking cessation. The score for each factor was determined by dividing the 5-year survival rate (%) by 10 and summing these scores to form a total score. MV models and the score were validated using bootstrapping with 1000 iterations from the original samples. The score for each prognostic factor ranged from 1 to 7 points with higher scores reflective of better survival. Total scores (sum of the scores from each independent prognostic factor) of 32–37 correlated with a 5-year survival of 8.3% (95% CI = 0–17.1%), 38–43 correlated with a 5-year survival of 20% (95% CI = 13–27%), 44–47 correlated with a 5-year survival of 48.3% (95% CI = 41.5–55.2%), 48–49 correlated to a 5-year survival of 72.1% (95% CI = 65.6–78.6%), and 50–52 correlated to a 5-year survival of 84.7% (95% CI = 79.6–89.8%). The bootstrap method confirmed the reliability of the score. Prognostic factors significantly associated with survival on both UV and MV analyses were used to construct a valid scoring system that can be used to predict survival of NSCLC patients. Optimally, this score could be used when counseling patients, and designing future trials. John Wiley & Sons, Ltd 2015-09 2015-06-23 /pmc/articles/PMC4567018/ /pubmed/26108458 http://dx.doi.org/10.1002/cam4.479 Text en © 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Schild, Steven E Tan, Angelina D Wampfler, Jason A Ross, Helen J Yang, Ping Sloan, Jeff A A new scoring system for predicting survival in patients with non-small cell lung cancer |
title | A new scoring system for predicting survival in patients with non-small cell lung cancer |
title_full | A new scoring system for predicting survival in patients with non-small cell lung cancer |
title_fullStr | A new scoring system for predicting survival in patients with non-small cell lung cancer |
title_full_unstemmed | A new scoring system for predicting survival in patients with non-small cell lung cancer |
title_short | A new scoring system for predicting survival in patients with non-small cell lung cancer |
title_sort | new scoring system for predicting survival in patients with non-small cell lung cancer |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567018/ https://www.ncbi.nlm.nih.gov/pubmed/26108458 http://dx.doi.org/10.1002/cam4.479 |
work_keys_str_mv | AT schildstevene anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT tanangelinad anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT wampflerjasona anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT rosshelenj anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT yangping anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT sloanjeffa anewscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT schildstevene newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT tanangelinad newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT wampflerjasona newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT rosshelenj newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT yangping newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer AT sloanjeffa newscoringsystemforpredictingsurvivalinpatientswithnonsmallcelllungcancer |